Home » Newsletters » BioWorld Science

BioWorld Science

July 21, 2021

View Archived Issues

Bacteriophage endolysin LysECD7 shows promising antibiofilm activity

Celgene opens enrollment in phase I study of CC-90011 in metastatic CRPC

Biodegradable polymeric solid implants developed for long-acting HIV pre-exposure prophylaxis

Lethal autoinflammatory syndrome linked to loss-of-function C2orf69 gene variants

Dosing begins in phase I study of HLX-04-O in China

Medshine Discovery patents new compounds for NASH

Tecnimede-Sociedade Tecnico-Medicinal discloses compounds for tuberculosis

Wigen Biomedicine Technology presents GTPase KRAS mutant inhibitors

Latvian Institute of Organic Synthesis discloses tubulin polymerization inhibitors

First participants dosed in phase Ib/IIa FOCUSC9 study of WVE-004

NIMIUM and Paraza partner to develop G3PP activators to treat cardiometabolic diseases

Updated interim data from ongoing phase I/IIa study of OpRegen in dry AMD with GA

Lantern reports promising new preclinical data for LP-184 in pancreatic cancer

CA-125 is a diagnostic marker of tuberculosis in patients without HIV

Affinia and IOB collaborate to design novel CNS promoters for gene therapy

German clearance for phase I/IIa study of HDP-101 in multiple myeloma

Poor sleep quality in people with HIV is linked to lower CSF Abeta42 levels

Rab35-silencing as new strategy to impair HIV propagation

IL-12 and IL-18 are highly secreted in patients with HIV/TB coinfection

FDA clears IND for phase I/II trial of ExoFlo to treat post-acute COVID-19 syndrome

DSMB recommends continuation of phase II trial of ANVS-401 in Alzheimer's disease

All together now: Cure research plays big role at IAS 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...